Zusammenfassung aller wichtigen Infos:
Bitte PDF im Vollbildmodus ansehen oder ausdrucken.
Flyer

---

Zusammensetzung (in einer Kapsel):
Vitamin С (Ascorbinsäure, Calcium Ascorbat, Ascorbyl-Palmitat
Extrakt (4:1) der Acerola-Früchte (Malpighia glabra L),
Hagebuttenpulver (Rosa rugosa)) – 175 mg
Zink (Zink Glucinat) – 3.75 mg
Selen (Selenium + GPM™) – 17 mkg
Extrakt (5:1) der Echinacea (Echinacea purpurea) (4% der polyphenolen Komponenten) – 160 mg
aromatisierter Knoblauch (Allium sativum L.) – 125 mg
Verpackung: 60 Kapseln

---

Beschreibung der Studie: Feuerwehr des Immunsystems*

„Rettungsdienst“ für das Immunsystem ohne Nebenwirkungen möglich ist wegen einzigartige Formel bestehend aus Vitamin С in fünf verschiedenen Formen ( die seine Bioverfügbarkeit verbessert), standardisierten Extrakte von Echinacea purpurea und Knoblauch, verdauliche Chelatform des Zinks, besonders gut verdauliche Form des Selens (Selenium + GPM™).
Die Untersuchungen haben gezeigt, dass Vitamin С die Schwierigkeit der Erkältungen senken und deren Dauer reduzieren hilft.
*Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999; 3:756-761.
*Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad SciUSA. 1971; 68:2678-2681.

Angemeldete Benutzer sehen mehr Anwendungsempfehlungen.

Studiennachweise:
1. Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999; 3:756-761.
2. Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad SciUSA. 1971; 68:2678-2681.
3. Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold. Ann Intern Med 1996;125:81-8.
4. Zinc lozenges reduce the duration of common cold symptoms. Nutr Rev 1997;55:82-8 [review].
5. Garland ML, Hagmeyer KO. The role of zinc lozenges in treatment of the common cold. Ann Pharmacother 1998;32:93-69 [review].
6. Peretz A, Néve J, Desmedt J, et al. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast. Am J Clin Nutr 1991;53:1323-8.
7. Melchart D, Linde K, Worku F, et al. Immunomodulation with Echinacea-a systematic review of controlled clinical trials. Phytomedicine 1994;1:245-54.
8. Dorn M, Knick E, Lewith G. Placebo-controlled, double-blind study of Echinacea pallida redix in upper respiratory tract infections. Comp Ther Med 1997;5:40-2.
9. Hoheisel O, Sandberg M, Bertram S, et al. Echinacea shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur J Clin Res 1997;9:261-8.
10. Braunig B, Dorn M, Knick E. Echinacea purpurea root for strengthening the immune response to flu-like infections. Zeitschrift Phytotherapie 1992;13:7-13.
11. Brikenborn RM, Shah DV, Degenring FH. Echinaforce® and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo-controlled, double-blind clinical trial. Phytomedicine 1999;6:1-5.
12. Schoneberger, D. 1992. The influence of immune-stimulating effects of pressed juice from Echinacea purpurea on the course and severity of colds. Forum Immunologie 2:18–22.
13. Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TD, Basu TK. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2004 Feb;29(1):75-83
14. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther. 2001 Jul-Aug;18(4):189-93.
15. Hughes BG, Lawson LD. Antimicrobial effects of Allium sativum L. (garlic), Allium ampeloprasum L. (elephant garlic) and Allium cepa L. (onion), garlic compounds and commercial garlic supplement products. Phytother Res 1991;5:154-8.
16. Hemilä H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress.Int J Sports Med. 1996 Jul;17(5):379-83
17. Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):594-603.